United States · FDA National Drug Code directory

ECHINACEA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
60986-2020_483b5b77-9991-87fa-e063-6394a90a6c1e
Product NDC
60986-2020
Form
TABLET, ORALLY DISINTEGRATING
Composition / generic term
ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS
Labeler
Marco Pharma International LLC.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
19920301
Source listing expiry
20271231

Source-listed ingredients

  • ECHINACEA ANGUSTIFOLIA — 1 [hp_X]/1
  • HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK — 2 [hp_X]/1
  • TRIBASIC CALCIUM PHOSPHATE — 3 [hp_X]/1
  • GOLDENSEAL — 4 [hp_X]/1
  • POLYGALA SENEGA ROOT — 4 [hp_X]/1
  • SILICON DIOXIDE — 4 [hp_X]/1
  • CONIUM MACULATUM FLOWERING TOP — 4 [hp_X]/1
  • SODIUM TETRACHLOROAURATE — 5 [hp_X]/1
  • OYSTER SHELL CALCIUM CARBONATE, CRUDE — 5 [hp_X]/1
  • FUCUS VESICULOSUS — 5 [hp_X]/1
  • LACHESIS MUTA VENOM — 8 [hp_X]/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (60986-2020-2) · 60986-2020-2

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →